The Use of Cyproheptadine in Pediatric Feeding Disorders

Completed · Phase 4

Conditions studied: Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder

In brief

The goal of this clinical trial is to learn if Cyproheptadine, an appetite stimulant, can improve eating habits in children with Pediatric Feeding Disorders. Pediatric Feeding Disorders is a broad term that describes disorders of eating-related behaviors that causes altered consumption of food and impairs physical or psychosocial health.

Key facts

Study ID

NCT06751290

Run by

University of Miami

People needed

18

Starts

2024-12-30

Expected to finish

2026-04-30

Last updated by the study team

2026-06-04

Who can join

Age: 2 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any patient aged 2-6 years of age who presents to Pediatric Gastroenterology Clinic with complaint of "poor weight gain, malnutrition, failure to thrive/weight faltering, picky eating, or feeding issues" who screens positive for a pediatric feeding disorder using the Child eating disorder questionnaire (CEBQ)
• Age Range: 2-6 years
• English or Spanish speaking

You may not qualify if…

• Patients who are tube fed
• Patients who are overweight (BMI at 85th%tile or greater)
• Patients who have active symptoms from a diagnosis of a GI disorder (Inflammatory Bowel Disease, Eosinophilic Esophagitis, Gastritis)
• Patients actively undergoing behavioral feeding therapy

Where it is running

• University of Miami Department of Pediatric Gastroenterology — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.